« Previous
Next »
Journal of Foot and Ankle Surgery
Volume 49, Issue 2
, Pages 159.e15-159.e20
, March 2010
Treatment of Metastatic Prostate Adenocarcinoma to the Calcaneus
References
- . Metastatic prostate carcinoma to the foot with magnetic resonance imaging and pathologic correlation. Foot Ankle Int. 1998;19(9):594–597
- . Prostate cancer metastases to the leg, ankle, and foot. J Am Podiatr Med Assoc. 2008;98(3):242–245
- . Metastatic skeletal disease of the foot: case reports and literature review. Foot Ankle Int. 2008;29(7):699–710
- . Metastatic tumors of the foot and ankle. Foot Ankle. 1988;8(5):243–247
- . Metastatic tumors to the bones of the foot. Cancer. 1976;37(3):1492–1495
- . Metastatic tumors of the foot: case report and literature review. Clin Orthop Relat Res. 1982;170:219–225
- . Metastatic tumours of bones of the hand and foot. A comparative review and report of 43 additional cases. Skeletal Radiol. 1987;16(5):387–392
- . Progressive sclerosis of isolated foot metastasis of prostate cancer. J Urol. 2002;167(3):1392
- . Heel pain as the inaugural manifestation of metastatic prostate cancer. Rev Rhum Engl Ed. 1996;63(11):870–871
- . Treatment of metastatic adenocarcinoma of the pelvis and the extremities. J Bone Joint Surg (Am). 1997;79:917–932
- . Predictors of survival in patients with bone metastasis of lung cancer. Clin Orthop Rel Res. 2008;466:729–736
- . The use of F-18 choline PET in the assessment of bone metastases in prostate cancer: correlation with morphological changes on CT. Mol Imaging Biol. 2009 Jul 9;[Epub ahead of print]
- . Procollagen type 1 amino-terminal propeptide: a marker for bone metastases in prostate carcinoma. Anticancer Res. 2009;29(2):671–673
- . What's new in musculoskeltal oncology. J Bone Joint Surg (Am). 2009;91:1546–1556
- . Receptor activator of NF-kappaB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells. Cell Res. 2008;18(8):858–870
- . EGFR ligand switch in late stage prostate cancer contributes to changes in cell signaling and bone remodeling. Prostate. 2009;69(5):528–537
- . RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes. Prostate. 2008;68(1):92–104
- . Osteoprotegerin and rank ligand expression in prostate cancer. Urology. 2001;57(4):611–616
Financial Disclosure: None reported.
Conflict of Interest: None reported.
PII: S1067-2516(09)00311-1
doi: 10.1053/j.jfas.2009.07.027
© 2010 American College of Foot and Ankle Surgeons. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Foot and Ankle Surgery
Volume 49, Issue 2
, Pages 159.e15-159.e20
, March 2010
